Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial.
Document Type
Journal Article
Publication Date
9-1-2017
Journal
Lancet Child Adolesc Health
Volume
1
Issue
1
Inclusive Pages
27-34
DOI
10.1016/S2352-4642(17)30009-3
APA Citation
Natukunda, E., Gaur, A., Kosalaraksa, P., Batra, J., Rakhmanina, N., Porter, D., Shao, Y., Zhang, H., Pikora, C., & Rhee, M. (2017). Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial.. Lancet Child Adolesc Health, 1 (1). http://dx.doi.org/10.1016/S2352-4642(17)30009-3
Peer Reviewed
1
